Referenser Enhetens för medicinsk bild, funktion och teknik, CLINTEC
(Peter Aspelin)
Granberg T, Martola J, Kristoffersen-Wiberg M, Aspelin P, Fredrikson S.Radiologically isolated syndrome incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult 12
Scler. 2012 Jul 3. [Epub ahead of print]
Kartalis N, Loizou L, Edsborg N, Segersvärd R, Albiin N. Optimising diffusion-weighted MR imaging for
demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold
techniques. Eur Radiol. 2012 Oct;22(10):2186-92. Epub 2012 May 2.
12
Nyman U, Almén T, Jacobsson B, Aspelin P. Are intravenous injections of contrast media really less
nephrotoxic than intra-arterial injections? Eur Radiol. 2012 Jun;22(6):1366-71. Epub 2012 Feb 4.
Review.
12
Svensson A, Nouhad J, Cederlund K, Aspelin P, Nyman U, Björk J, Torkel BB. Hepatic contrast medium
enhancement at computed tomography and its correlation with various body size measures. Acta Radiol.
2012 Jul;53(6):601-6. Epub 2012 Jul 3.
12
Brismar TB, Kartalis N, Kylander C, Albiin N. MRI of colorectal cancer liver metastases: comparison of
orally administered manganese with intravenously administered gadobenate dimeglumine. Eur Radiol.
2012 Mar;22(3):633-41. Epub 2011 Sep 28.
11
Martola J, Bergström J, Fredrikson S, Stawiarz L, Hillert J, Zhang Y, Flodmark O, Lilja A, Ekbom A,
Aspelin P, Wiberg MK. A longitudinal observational study of brain atrophy rate reflecting four decades of
multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images.
Neuroradiology. 2010 Feb;52(2):109-17. Epub 2009 Sep 23.
09
Kartalis N, Lindholm TL, Aspelin P, Permert J, Albiin N. Diffusion-weighted magnetic resonance imaging
of pancreas tumours. Eur Radiol. 2009 Mar 24. [Epub ahead of print].
09
Lindsköld L, Aspelin P, Jacobsson B, Lundberg N. The use of simulation in radiology. Radiol Manage.
2008 May-Jun;30(3):55-62. Review.
08
Axelsson R, Herlin G, Bååth M, Aspelin P, Kölbeck KG. Role of scintigraphy with technetium-99m
depreotide in the diagnosis and management of patients with suspected lung cancer. Acta Radiol. 2008
Apr;49(3):295-302.
08
Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach.
Circulation. 2006 Apr 11;113(14):1799-806.
06
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Lundkvist J. Cost-effectiveness of iodixanol
in patients at high risk of contrast-inducednephropathy. Am Heart J. 2005 Feb;149(2):298-303.
05
Shalabi A, Movin T, Kristoffersen-Wiberg M, Aspelin P, Svensson L. Reliability in the assessment of
tendon volume and intratendinous signal of theAchilles tendon on MRI: a methodological description.
Knee Surg Sports Traumatol Arthrosc. 2005 Sep;13(6):492-8. Epub 2004 Nov 26.
04
Szabó BK, Wiberg MK, Boné B, Aspelin P. Application of artificial neural networks to the analysis of
dynamic MR imagingfeatures of the breast. Eur Radiol. 2004 Jul;14(7):1217-25. Epub 2004 Mar 18.
04
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ;Nephrotoxicity in High-Risk
Patients Study of Iso-Osmolar and Low-OsmolarNon-Ionic Contrast Media Study Investigators.
Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003 Feb 6;348(6):4919.
03
Cederlund K, Tylén U, Jorfeldt L, Aspelin P. Classification of emphysema in candidates for lung volume
reduction surgery: anew objective and surgically oriented model for describing CT severity
andheterogeneity. Chest. 2002 Aug;122(2):590-6.
02
